GSK announces appointments to designate Haleon Board
Demerger and listing of Haleon is expected in July 2022
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
GSK
GSK provides update on phase-III RSV maternal vaccine candidate
The company has decided to stop enrollment and vaccination in trials evaluating its potential Respiratory Syncytial Virus (RSV)…
GSK to name consumer healthcare unit ‘Haleon’ after spin-off
Last June, GSK announced plans to divest the business, which includes brands such as Sensodyne toothpaste and Advil painkillers,…
Sanofi and GSK to seek regulatory authorisation for COVID-19 vaccine
Final analysis of the global VAT02 booster trial confirms universal ability to boost neutralising antibodies 18-to 30-fold across…
Moderna to develop mRNA-based shingles vaccine
The success of COVID-19 vaccines based on messenger RNA (mRNA) technology from Moderna and rival Pfizer has prompted efforts to…
Working in finance is more about talent equality
Puja Thakur, CFO and Executive Director, GlaxoSmithKline Pharmaceuticals (GSK), in an interaction with Ashwini Prakash, Managing…
Sanofi and GSK say COVID-19 vaccine booster candidate gives good immune response
The French and British partners said they expect more results of the late-stage phase-III study of their recombinant adjuvanted…
Antibody drug works against COVID-19 Omicron variant: GSK
In a statement, the British drugmaker said that lab tests and a study on hamsters have demonstrated the Sotrovimab antibody…
Schneider Electric launches programme to increase access to renewable energy for pharmaceutical…
The collaboration aims to accelerate the adoption of renewable energy and reduce greenhouse gas emissions within the…
GSK receives US FDA approval for Jemperli to treat advanced solid tumours
GARNET study demonstrated an objective response rate of 41.6 per cent across dMMR solid tumours